PEN 221

Drug Profile

PEN 221

Alternative Names: BTP-227; PEN-221

Latest Information Update: 22 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tarveda Therapeutics
  • Class Antineoplastics; Drug conjugates
  • Mechanism of Action DNA synthesis inhibitors; Somatostatin receptor 2 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Neuroendocrine tumours; Small cell lung cancer

Most Recent Events

  • 01 Jun 2018 Interim efficacy, safety and pharmacokinetics data from a Phase-I/II trial in advanced neuroendocrine tumor (NET) or small cell lung cancer (SCLC) presented at 54th Annual Meeting of the American Society of Clinical Oncology (ASCO-2018)
  • 24 Apr 2018 Phase-II clinical trials in Neuroendocrine tumours (Late-stage disease, Second-line therapy or greater) in United Kingdom, USA (IV) (NCT02936323)
  • 24 Apr 2018 Phase-II clinical trials in Small cell lung cancer (Late-stage disease, Second-line therapy or greater) in United Kingdom, USA (IV) (NCT02936323)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top